Sergei S Kutseikin

6PUBLICATIONS
36CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Proteins and peptidesCharacterisation of biological macromoleculesOptical properties of materials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 27, 2026
Pharmacological Inhibition of SLC33A1 Promotes Endoplasmic Reticulum Hyperoxidation and Induces Adaptive IRE1/XBP1s Signaling.

Sergei Kutseikin, Maria Rafiq, Prerona Bora

|Jul 16, 2025
Drug Repurposing Screen Identifies an HRI Activating Compound that Promotes Adaptive Mitochondrial Remodeling in MFN2-deficient Cells.

Prerona Bora, Mashiat Zaman, Samantha Oviedo

|Apr 16, 2025
Phenylhydrazone-based Endoplasmic Reticulum Proteostasis Regulator Compounds with Enhanced Biological Activity.

Gabriel M Kline, Lisa Boinon, Adrian Guerrero

|Apr 25, 2024
The Glycolytic Metabolite Methylglyoxal Covalently Inactivates the NLRP3 Inflammasome.

Caroline Stanton, Chavin Buasakdi, Jie Sun

|Jan 21, 2023
Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment.

Ivan D Osipov, Valeriia A Vasikhovskaia, Daria S Zabelina

|Apr 12, 2020
Human Serum Albumin Labelled with Sterically-Hindered Nitroxides as Potential MRI Contrast Agents.

Sergey Dobrynin, Sergei Kutseikin, Denis Morozov

Pageof 1